Cited by 102HIV/AIDS drug development and treatmentComplementary and Alternative Medicine StudiesPharmacogenetics and Drug Metabolism

The DOI matches its Crossref record; 79 of the 79 references it cites were found in a registry or an index.

HIV/AIDS: Interactions between Natural Health Products and Antiretroviral Drugs: Pharmacokinetic and Pharmacodynamic Effects

Lee, Lawrence S., Andrade, Adriana S. A., Flexner, Charles·2006·Clinical Infectious Diseases

Abstract

Concurrent use of natural health products (NHPs) with antiretroviral drugs (ARVs) is widespread among human immunodeficiency virus-infected patients. This article reviews the clinical pharmacokinetic and pharmacodynamic interactions between NHPs and ARVs. Many NHPs are complex mixtures and are likely to contain organic compounds that may induce and/or inhibit drug metabolizing enzymes and drug transporters. Although the weight of evidence for the effects of certain NHPs varies and many studies of these products lack scientific rigor, it has been observed that St. John's wort clearly induces cytochrome P450 3A4 and P-glycoprotein and reduces protease inhibitor and nonnucleoside reverse-transcriptase inhibitor concentrations, thereby increasing the likelihood of therapeutic failure. Limited clinical research suggests that intake of garlic and vitamin C results in reductions in ARV concentrations. The intake of milk thistle, Echinacea species, and goldenseal inhibits cytochrome P450 enzymes in vitro and may increase ARV concentrations, but by clinically unimportant amounts. Intake of fish oil reduces ARV-induced hypertriglyceridemia without significantly affecting lopinavir concentrations. Before recommending the use of NHPs as adjuncts to ARV use, studies should first exclude significant pharmacokinetic interactions and ensure that ARV efficacy is maintained.

Overview

Integrity signals

Registry

Crossref · 10.1086/507894

Cites

79 of 79 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Show all 78 references

Research works printed but not linked: 8

  1. Tindle HA, 2005, Altern Ther Health Med, 11, 42
  2. Rivera JO, 2005, J Natl Med Assoc, 97, 1686
  3. Foster BC, 2001, J Pharm Pharm Sci, 4, 176
  4. Tattelman E, 2005, Am Fam Physician, 72, 103
  5. Laroche M, 1998, Can J Infect Dis, 9, 471P
  6. Sangkitporn S, 2005, Southeast Asian J Trop Med Public Health, 36, 704
  7. Ramgolam V, 2000, Ann Acad Med Singapore, 29, 11
  8. Gerber J, Kitch D, Aberg J, etal The safety and efficacy of fish oil in combination with fenofibrate in subjects on ART with hypertriglyceridemia who had an incomplete response to either agent alone: results of A5186 [abstract 146]. In: Program and abstracts of the 13th Conference on Retroviruses and Opportunistic Infections. Alexandria, VA: Foundation for Retrovirology and Human Health, 2006:100.

Cited by

Sorted by citations

Items 101–102 of 102

Metadata

Authors
Lee, L. S., Andrade, A. S. A., & Flexner, C.
Affiliations
Johns Hopkins University (US)
Corresponding author
Flexner, Charles
Venue
Clinical Infectious Diseases
Published
2006-10-15
Volume
43
Issue
8
Pages
1052-1059
ISSN
  • 1058-4838 (ISSN-L)
  • 1537-6591
OpenAlex
W2111738803
Cited by
102
References
78
Citations by year
2026: 2 · 2025: 5 · 2024: 3 · 2023: 2 · 2022: 2 · 2021: 2 · 2020: 5 · 2019: 6 · 2018: 1 · 2017: 2 · 2016: 2 · 2015: 5 · 2014: 2 · 2013: 8 · 2012: 14
FWCI
3.49
Type
journal article
Language
en
Open access
closed
Locations
  • Clinical Infectious Diseases (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Center for Complementary and Alternative Medicine
  • National Center for Complementary and Integrative Health (F05-AT 02031, F05AT002031)
Topics
  • Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
  • Health Sciences › Medicine › Complementary and alternative medicine › Complementary and Alternative Medicine Studies
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
Keywords
natural health products, antiretroviral drugs, drug interactions, HIV/AIDS, pharmacokinetic interactions, pharmacodynamic interactions, Hypericum perforatum, CYP3A4, P-glycoprotein, protease inhibitors, non-nucleoside reverse transcriptase inhibitors, garlic, vitamin C, Silybum marianum, Echinacea, goldenseal, fish oil, lopinavir, drug-metabolizing enzymes, drug transporters
MeSH terms
Biological Availability, Cytochrome P-450 Enzyme System, Humans, Plant Extracts, Plants, Medicinal, Glucuronosyltransferase, ATP Binding Cassette Transporter, Subfamily B, Member 1, Herb-Drug Interactions, Anti-Retroviral Agents, Cytochrome P-450 CYP3A

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review